Skip navigation
  • 中文
  • English

DSpace CRIS

  • DSpace logo
  • Home
  • Organizations
  • Researchers
  • Research Outputs
  • Explore by
    • Organizations
    • Researchers
    • Research Outputs
  • Academic & Publications
  • Sign in
  • 中文
  • English
  1. NTU Scholars
  2. 醫學院
  3. 醫學系
Please use this identifier to cite or link to this item: https://scholars.lib.ntu.edu.tw/handle/123456789/539506
Title: Adverse events following immunization with the live-attenuated recombinant Japanese encephalitis vaccine (IMOJEV?) in Taiwan, 2017–18
Authors: Ma H.-Y.
Lai C.-C.
Chiu N.-C.
PING-ING LEE 
Keywords: Adverse event; Chimeric; Live-attenuated recombinant Japanese encephalitis vaccine; National immunization program; Vaccine safety
Issue Date: 2020
Publisher: Elsevier Ltd
Journal Volume: 38
Journal Issue: 33
Start page/Pages: 5219-5222
Source: Vaccine
Abstract: 
Background: Japanese encephalitis (JE) is a significant public health concern in the Asia-Pacific region, with a case-fatality rate of around 20% for those who develop encephalitis. Mouse-brain derived vaccines against JE have been used in the publicly funded national immunization program (NIP) in Taiwan since 1968. They were replaced with a live-attenuated recombinant vaccine (JE-CV, IMOJEV?) in May 2017. We assessed reports of adverse events (AE) following the introduction of JE-CV into the Taiwan NIP to characterize its post-licensure safety profile. Methods: AEs reported between 1 May 2017 and 31 December 2018 post vaccination with JE-CV were extracted from the National Adverse Drug Reactions (ADR) Reporting System, a passive surveillance system run by the Taiwan Food and Drug Administration. The report rates were calculated based on the number of doses distributed by the manufacturer during the assessment period. Results: There were 51 AEs reported among 30 subjects (12 girls and 18 boys; mean age 25 months), with a reporting rate of 4.7 AEs per 100,000 doses distributed. The AEs occurred after a median of. 1-day post vaccination. Eight subjects had received concomitant vaccination with another vaccines. There were four serious AEs reported: febrile seizure, acute renal failure, viral respiratory tract infection, and injection site cellulitis. None of these serious AEs were classified as being causally related to JE-CV vaccination. Conclusion: These post-licensure AE surveillance data confirm the favorable safety profile of JE-CV. ? 2020 The Authors
URI: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85086506182&doi=10.1016%2fj.vaccine.2020.06.008&partnerID=40&md5=4618da774e102eabc326d2d8f755650a
https://scholars.lib.ntu.edu.tw/handle/123456789/539506
ISSN: 0264-410X
DOI: 10.1016/j.vaccine.2020.06.008
metadata.dc.subject.other: diphtheria pertussis poliomyelitis tetanus Haemophilus influenzae type b vaccine; hepatitis A vaccine; Japanese encephalitis vaccine; live vaccine; measles mumps rubella vaccine; Pneumococcus vaccine; recombinant Japanese encephalitis vaccine; unclassified drug; Japanese encephalitis vaccine; virus antibody; acute kidney failure; adverse event; age distribution; Article; behavior change; child; conjunctivitis; decreased appetite; diarrhea; drug eruption; drug industry; drug monitoring; drug safety; drug surveillance program; eye discharge; fatigue; febrile convulsion; female; fever; focal glomerulosclerosis; headache; hematuria; human; immunization; injection site cellulitis; injection site edema; injection site erythema; injection site reaction; injection site swelling; male; preschool child; priority journal; rhinorrhea; school child; sex difference; side effect; tachypnea; Taiwan; throat disease; viral respiratory tract infection; vomiting; Asia; Japanese encephalitis; vaccination; Antibodies, Viral; Asia; Encephalitis, Japanese; Humans; Japanese Encephalitis Vaccines; Taiwan; Vaccination
[SDGs]SDG3
Appears in Collections:醫學系

Show full item record

SCOPUSTM   
Citations

5
checked on May 19, 2022

WEB OF SCIENCETM
Citations

4
checked on May 8, 2022

Page view(s)

17
checked on Apr 30, 2022

Google ScholarTM

Check

Altmetric

Altmetric

Related Items in TAIR


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Sherpa Romeo網站查詢,以確認出版單位之版權政策。
    Please use Sherpa Romeo to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)
Build with DSpace-CRIS - Extension maintained and optimized by Logo 4SCIENCE Feedback